Who is sponsoring NCT06379802?

NCT06379802 is sponsored by Vastra Gotaland Region.

What drugs are being tested in NCT06379802?

Interventions in NCT06379802: Individualized physical activity and diet.

What condition does NCT06379802 study?

NCT06379802 studies Overweight.

Is NCT06379802 still recruiting?

NCT06379802 is currently active, enrolled. Last updated 26 March 2025.

Last reviewed 2025-03-26 · How we verify

NCT06379802: LI-PAD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lifestyle Intervention With Physical Activity and Diet

Active, enrolled NA Last updated 26 March 2025

What this trial tests

NA trial testing Individualized physical activity and diet in Overweight in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

12 February 2024

Primary endpoint
31 December 2025

31 December 2027

Quick facts

Lead sponsor	Vastra Gotaland Region
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	120
Start date	12 February 2024
Primary completion	31 December 2025
Estimated completion	31 December 2027
Sites	1 location across Sweden

Drugs / interventions tested

Individualized physical activity and diet

Conditions studied

Overweight — all drugs for Overweight →

Sponsor

Vastra Gotaland Region — full company profile →

Who can join

Adults 45 to 65, any sex, with Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this pilot randomized controlled trial LI-PAD is to identify whether a 6-month intervention approach to individually optimize lifestyle behavior, physical activity, and diet, is feasible and leads to larger improvements in body weight, cardiovascular disease risk factors, and health-related quality of life compared to simple written lifestyle advice, in individuals with overweight or obesity. The intervention group will be offered individual support for lifestyle behavioral change (precision health) and the control group will be offered written lifestyle advice, following national recommendations. In total, 60 population-based participants and 60 controls from the Gothenburg area, aged 45-65 years, will be recruited.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

An individualised Lifestyle Intervention with Physical Activity and Diet in individuals with overweight and obesity (LI-PAD)-study protocol of a 6-month randomised controlled study {1a}.
Persson CU, Arvidsson D, Fridolfsson J, Bergström G, et al · · 2026 · PMID 41840656 · DOI 10.1186/s13063-026-09606-6

Verify or expand the search:

Other recruiting trials for Overweight

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting

Other Vastra Gotaland Region trials

Trials by the same sponsor.

NCT07430865 — The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation · NA · recruiting
NCT07472335 — Home-based Acute Care for Older Persons Initiated by the Emergency Medical and Ambulance Services - a Retrospective Obse · not yet recruiting
NCT07246577 — The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant C · recruiting
NCT07449338 — Prospective Cohort Study of Response and Tolerability of Accelerated Intermittent Theta-burst Stimulation (1W-AiTBS) · not yet recruiting
NCT07334340 — Modified vs Standard CDED: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06379802 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vastra Gotaland Region
Last refreshed: 26 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06379802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing